List of articles with "Armata Pharmaceuticals"

Armata Q3 2025 Update

Armata Q3 2025 Update

United States Los Angeles Armata Pharmaceuticals AP-SA02 bacteriophage
Phage Manufacturing

Phage Manufacturing

United States Los Angeles Armata Pharmaceuticals antibiotic resistance Bacteriophage Therapy
Positive Data from AP-SA02

Positive Data from AP-SA02

United States Atlanta Armata Pharmaceuticals AP-SA02 IDWeek 2025
Armata at IDWeek 2025

Armata at IDWeek 2025

United States Atlanta Armata Pharmaceuticals Bacteriophage Therapy AP-SA02
Armata's New Phage Research

Armata's New Phage Research

USA Los Angeles phage therapy Armata Pharmaceuticals Pa223
Armata at H.C. Wainwright

Armata at H.C. Wainwright

United States New York Armata Pharmaceuticals Bacteriophage Therapy H.C. Wainwright
Armata's Q2 2025 Highlights

Armata's Q2 2025 Highlights

United States Los Angeles Armata Pharmaceuticals AP-SA02 bacteriophage
Armata's Phage Therapy Study

Armata's Phage Therapy Study

USA Los Angeles Armata Pharmaceuticals AP-SA02 diSArm Study
Armata Q1 2025 Results

Armata Q1 2025 Results

USA Los Angeles biotechnology Armata Pharmaceuticals AP-SA02
Armata Gains $4.65M Funding

Armata Gains $4.65M Funding

USA Los Angeles Armata Pharmaceuticals AP-SA02 diSArm Trial
Armata Q4 2024 Results

Armata Q4 2024 Results

USA Los Angeles phage therapy Armata Pharmaceuticals AP-PA02
Armata Secures $10 Million

Armata Secures $10 Million

USA Los Angeles Armata Pharmaceuticals Bacteriophage Therapy Innoviva
Birx at Bacteriophage Summit

Birx at Bacteriophage Summit

United States Boston Armata Pharmaceuticals Deborah Birx Bacteriophage Therapy
Armata's New Phage Therapy

Armata's New Phage Therapy

United States Los Angeles Armata Pharmaceuticals AP-PA02 Phase 2 Trials

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.